Glycobiology simplified: Diverse roles of glycan recognition in inflammation

Journal of Leukocyte Biology

Volumn 99, Issue 6, 2016, Pages 825-838

  Schnaar, Ronald L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fucose; Galectin; Lectin; Selectin; Sialic acid; Siglec

Indexed keywords

CARBOHYDRATE; DECTIN 1; DECTIN 2; ECALECTIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GALECTIN 1; GALECTIN 3; GLYCAN; GLYCAN BINDING PROTEIN; GLYCOME; GLYCOPROTEIN; HYALURONIC ACID BINDING PROTEIN; MONOSACCHARIDE; PADGEM PROTEIN; PROTEIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN 8; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN 9; UNCLASSIFIED DRUG; POLYSACCHARIDE;

CELL INTERACTION; CHEMICAL STRUCTURE; COMPLEX FORMATION; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; IMMUNITY; INFLAMMATION; LEUKOCYTE; MOLECULAR PATHOLOGY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; REVIEW; ANIMAL; METABOLISM; PROCEDURES;

ANIMALS; GLYCOMICS; GLYCOSYLATION; HUMANS; INFLAMMATION; POLYSACCHARIDES;

EID: 84971451877     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3RI0116-021R     Document Type: Review

References (96)

1. Laine, R. A. (1994) A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 3 1012 structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems. Glycobiology 4, 759-767.
2. Cummings, R. D., Pierce, J. M. (2014) The challenge and promise of glycomics. Chem. Biol. 21, 1-15.
3. Varki, A., Cummings, R. D., Aebi, M., Packer, N. H., Seeberger, P. H., Esko, J. D., Stanley, P., Hart, G., Darvill, A., Kinoshita, T., Prestegard, J. J., Schnaar, R. L., Freeze, H. H., Marth, J. D., Bertozzi, C. R., Etzler, M. E., Frank, M., Vliegenthart, J. F., Lütteke, T., Perez, S., Bolton, E., Rudd, P., Paulson, J., Kanehisa, M., Toukach, P., Aoki-Kinoshita, K. F., Dell, A., Narimatsu, H., York, W., Taniguchi, N., Kornfeld, S. (2015) Symbol nomenclature for graphical representations of glycans. Glycobiology 25, 1323-1324.
4. Marth, J. D., Grewal, P. K. (2008) Mammalian glycosylation in immunity. Nat. Rev. Immunol. 8, 874-887.
5. van Kooyk, Y., Rabinovich, G. A. (2008) Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 9, 593-601.
6. Johnson, J. L., Jones, M. B., Ryan, S. O., Cobb, B. A. (2013) The regulatory power of glycans and their binding partners in immunity. Trends Immunol. 34, 290-298.
7. Rabinovich, G. A., van Kooyk, Y., Cobb, B. A. (2012) Glycobiology of immune responses. Ann. N. Y. Acad. Sci. 1253, 1-15.
8. Buzás, E. I., György, B., Pásztói, M., Jelinek, I., Falus, A., Gabius, H. J. (2006) Carbohydrate recognition systems in autoimmunity. Autoimmunity 39, 691-704.
9. Varki, A. (2011) Evolutionary forces shaping the Golgi glycosylation machinery: why cell surface glycans are universal to living cells. Cold Spring Harb. Perspect. Biol. 3, a005462.
10. Cohen, M., Varki, A. (2010) The sialome—far more than the sum of its parts. OMICS 14, 455-464.
11. Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., Etzler, M. E. 2009. Essentials of Glycobiology. [Second Edition]. Cold Spring Harbor Laboratory Press, New York.
12. Taylor, M. E., Drickamer, K. (2014) Convergent and divergent mechanisms of sugar recognition across kingdoms. Curr. Opin. Struct. Biol. 28, 14-22.
13. Cummings, R. D. (2009) The repertoire of glycan determinants in the human glycome. Mol. Biosyst. 5, 1087-1104.
14. Rillahan, C. D., Paulson, J. C. (2011) Glycan microarrays for decoding the glycome. Annu. Rev. Biochem. 80, 797-823.
15. Palma, A. S., Feizi, T., Childs, R. A., Chai, W., Liu, Y. (2014) The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome. Curr. Opin. Chem. Biol. 18, 87-94.
16. Taylor, M. E., Drickamer, K. 2011. Introduction to Glycobiology. [Third Edition]. Oxford University Press, Oxford., 283 pp.
17. Feizi, T. E., Haltiwanger, R. S. (2015) Editorial overview: carbohydrateprotein interactions and glycosylation: glycan synthesis and recognition: finding the perfect partner in a sugar-coated life. Curr. Opin. Struct. Biol. 34, 7-9.
18. Schnaar, R. L., Gerardy-Schahn, R., Hildebrandt, H. (2014) Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol. Rev. 94, 461-518.
19. Misra, S., Hascall, V. C., Markwald, R. R., Ghatak, S. (2015) Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front. Immunol. 6, 201.
20. Pomin, V. H. (2015) Sulfated glycans in inflammation. Eur. J. Med. Chem. 92, 353-369.
21. Kinoshita, T., Fujita, M. (2016) Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling. J. Lipid Res. 57, 6-24.
22. Baudoin, L., Issad, T. (2014) O-GlcNAcylation and inflammation: a vast territory to explore. Front. Endocrinol. (Lausanne) 5, 235.
23. Sarrazin, S., Lamanna, W. C., Esko, J. D. (2011) Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 3, a004952.
24. Anish, C., Schumann, B., Pereira, C. L., Seeberger, P. H. (2014) Chemical biology approaches to designing defined carbohydrate vaccines. Chem. Biol. 21, 38-50.
25. McEver, R. P. (2015) Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc. Res. 107, 331-339.
26. Marquardt, T., Lühn, K., Srikrishna, G., Freeze, H. H., Harms, E., Vestweber, D. (1999) Correction of leukocyte adhesion deficiency type II with oral fucose. Blood 94, 3976-3985.
27. Telen, M. J., Wun, T., McCavit, T. L., De Castro, L. M., Krishnamurti, L., Lanzkron, S., Hsu, L. L., Smith, W. R., Rhee, S., Magnani, J. L., Thackray, H. (2015) Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use. Blood 125, 2656-2664.
28. Zarbock, A., Ley, K., McEver, R. P., Hidalgo, A. (2011) Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood 118, 6743-6751.
29. Somers, W. S., Tang, J., Shaw, G. D., Camphausen, R. T. (2000) Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLeX and PSGL-1. Cell 103, 467-479.
30. Leppänen, A., White, S. P., Helin, J., McEver, R. P., Cummings, R. D. (2000) Binding of glycosulfopeptides to P-selectin requires stereospecific contributions of individual tyrosine sulfate and sugar residues. J. Biol. Chem. 275, 39569-39578.
31. Kobzdej, M. M., Leppänen, A., Ramachandran, V., Cummings, R. D., McEver, R. P. (2002) Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells. Blood 100, 4485-4494.
32. Nimrichter, L., Burdick, M. M., Aoki, K., Laroy, W., Fierro, M. A., Hudson, S. A., Von Seggern, C. E., Cotter, R. J., Bochner, B. S., Tiemeyer, M., Konstantopoulos, K., Schnaar, R. L. (2008) E-selectin receptors on human leukocytes. Blood 112, 3744-3752.
33. Lee, R. T., Lee, Y. C. (2000) Affinity enhancement by multivalent lectincarbohydrate interaction. Glycoconj. J. 17, 543-551.
34. Regina Todeschini, A., Hakomori, S. I. (2008) Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim. Biophys. Acta 1780, 421-433.
35. Hanna, S., Etzioni, A. (2012) Leukocyte adhesion deficiencies. Ann. N. Y. Acad. Sci. 1250, 50-55.
36. Etzioni, A., Frydman, M., Pollack, S., Avidor, I., Phillips, M. L., Paulson, J. C., Gershoni-Baruch, R. (1992) Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl. J. Med. 327, 1789-1792.
37. Lühn, K., Wild, M. K., Eckhardt, M., Gerardy-Schahn, R., Vestweber, D. (2001) The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat. Genet. 28, 69-72.
38. Lühn, K., Marquardt, T., Harms, E., Vestweber, D. (2001) Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts. Blood 97, 330-332.
39. Freeze, H. H., Chong, J. X., Bamshad, M. J., Ng, B. G. (2014) Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am. J. Hum. Genet. 94, 161-175.
40. Chang, J., Patton, J. T., Sarkar, A., Ernst, B., Magnani, J. L., Frenette, P. S. (2010) GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice. Blood 116, 1779-1786.
41. von Itzstein, M. (2007) The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug Discov. 6, 967-974.
42. Ernst, B., Magnani, J. L. (2009) From carbohydrate leads to glycomimetic drugs. Nat. Rev. Drug Discov. 8, 661-677.
43. Macauley, M. S., Crocker, P. R., Paulson, J. C. (2014) Siglec-mediat edregulation of immune cell function in disease. Nat. Rev. Immunol. 14, 653-666.
44. Crocker, P. R., Paulson, J. C., Varki, A. (2007) Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7, 255-266.
45. Kiwamoto, T., Kawasaki, N., Paulson, J. C., Bochner, B. S. (2012) Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. Pharmacol. Ther. 135, 327-336.
46. Bochner, B. S., Zimmermann, N. (2015) Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation. J. Allergy Clin. Immunol. 135, 598-608.
47. O’Neill, A. S., van den Berg, T. K., Mullen, G. E. (2013) Sialoadhesin—a macrophage-restricted marker of immunoregulation and inflammation. Immunology 138, 198-207.
48. Wang, L., Cummings, R. D., Smith, D. F., Huflejt, M., Campbell C. T., Gildersleeve, J. C., Gerlach, J. Q., Kilcoyne, M., Joshi, L., Serna, S., Reichardt, N. C., Parera Pera, N., Pieters, R. J., Eng, W., Mahal, L. K. (2014) Cross-platform comparison of glycan microarray formats. Glycobiology 24, 507-517.
49. Arthur, C. M., Cummings, R. D., Stowell, S. R. (2014) Using glycan microarrays to understand immunity. Curr. Opin. Chem. Biol. 18, 55-61.
50. Song, X., Heimburg-Molinaro, J., Cummings, R. D., Smith, D. F. (2014) Chemistry of natural glycan microarrays. Curr. Opin. Chem. Biol. 18, 70-77.
51. Monneau, Y., Arenzana-Seisdedos, F., Lortat-Jacob, H. (2015) The sweet spot: how GAGs help chemokines guide migrating cells. J. Leukoc. Biol. doi:jlb.3MR0915-440R [Epub ahead of print].
52. Chang, Y. C., Nizet, V. (2014) The interplay between siglecs and sialylated pathogens. Glycobiology 24, 818-825.
53. Schleimer, R. P., Schnaar, R. L., Bochner, B. S. (2016) Regulation of airway inflammation by siglec-8 and siglec-9 sialoglycan ligand expression. Curr. Opin. Allergy Clin. Immunol. 16, 24-30.
54. O’Reilly, M. K., Paulson, J. C. (2009) Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol. Sci. 30, 240-248.
55. Nutku, E., Aizawa, H., Hudson, S. A., Bochner, B. S. (2003) Ligation of siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101, 5014-5020.
56. von Gunten, S., Yousefi, S., Seitz, M., Jakob, S. M., Schaffner, T., Seger, R., Takala, J., Villiger, P. M., Simon, H. U. (2005) Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 106, 1423-1431.
57. Nutku-Bilir, E., Hudson, S. A., Bochner, B. S. (2008) Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways. Am. J. Respir. Cell Mol. Biol. 38, 121-124.
58. Hudson, S. A., Bovin, N. V., Schnaar, R. L., Crocker, P. R., Bochner, B. S. (2009) Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic siglec-8 ligand, polymeric 69-sulfated sialyl Lewis x. J. Pharmacol. Exp. Ther. 330, 608-612.
59. Gao, P. S., Shimizu, K., Grant, A. V., Rafaels, N., Zhou, L. F., Hudson, S. A., Konno, S., Zimmermann, N., Araujo, M. I., Ponte, E. V., Cruz, A. A., Nishimura, M., Su, S. N., Hizawa, N., Beaty, T. H., Mathias, R. A., Rothenberg, M. E., Barnes, K. C., Bochner, B. S. (2010) Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (siglec-8) gene are associated with susceptibility to asthma. Eur. J. Hum. Genet. 18, 713-719.
60. Padler-Karavani, V., Hurtado-Ziola, N., Chang, Y. C., Sonnenburg, J. L., Ronaghy, A., Yu, H., Verhagen, A., Nizet, V., Chen, X., Varki, N., Varki, A., Angata, T. (2014) Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related siglecs in primates. FASEB J. 28, 1280-1293.
61. Angata, T., Margulies, E. H., Green, E. D., Varki, A. (2004) Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms. Proc. Natl. Acad. Sci. U. S. A. 101, 13251-13256.
62. Stencel-Baerenwald, J. E., Reiss, K., Reiter, D. M., Stehle, T., Dermody, T. S. (2014) The sweet spot: defining virus-sialic acid interactions. Nat. Rev. Microbiol. 12, 739-749.
63. Tateno, H., Crocker, P. R., Paulson, J. C. (2005) Mouse siglec-F and human siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 69-sulfo-sialyl Lewis x as a preferred glycan ligand. Glycobiology 15, 1125-1135.
64. Zhang, M., Angata, T., Cho, J. Y., Miller, M., Broide, D. H., Varki, A. (2007) Defining the in vivo function of siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood 109, 4280-4287.
65. McMillan, S. J., Richards, H. E., Crocker, P. R. (2014) Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model. Immunol. Lett. 160, 11-16.
66. Kiwamoto, T., Brummet, M. E., Wu, F., Motari, M. G., Smith, D. F., Schnaar, R. L., Zhu, Z., Bochner, B. S. (2014) Mice deficient in the St3gal3 gene product a2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation. J. Allergy Clin. Immunol. 133, 240-247.
67. Suzukawa, M., Miller, M., Rosenthal, P., Cho, J. Y., Doherty, T. A., Varki, A., Broide, D. (2013) Sialyltransferase ST3Gal-III regulates siglec-F ligand formation and eosinophilic lung inflammation in mice. J. Immunol. 190, 5939-5948.
68. McMillan, S. J., Sharma, R. S., McKenzie, E. J., Richards, H. E., Zhang, J., Prescott, A., Crocker, P. R. (2013) Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b b2-integrindependent signaling. Blood 121, 2084-2094.
69. Spence, S., Greene, M. K., Fay, F., Hams, E., Saunders, S. P., Hamid, U., Fitzgerald, M., Beck, J., Bains, B. K., Smyth, P., Themistou, E., Small, Johnston J. A., Fallon, P. G., Burrows, J. F., McAuley, D. F., Kissenpfennig, A., Scott, C. J. (2015) Targeting siglecs with a sialic acid-decorated nanoparticle abrogates inflammation. Sci. Transl. Med. 7, 303ra140.
70. Angata, T., Nycholat, C. M., Macauley, M. S. (2015) Therapeutic targeting of siglecs using antibody- and glycan-based approaches. Trends Pharmacol. Sci. 36, 645-660.
71. Rillahan, C. D., Schwartz, E., McBride, R., Fokin, V. V., Paulson, J. C. (2012) Click and pick: identification of sialoside analogues for siglecbased cell targeting. Angew. Chem. Int. Ed. Engl. 51, 11014-11018.
72. Drickamer, K., Taylor, M. E. (2015) Recent insights into structure sand functions of C-type lectins in the immune system. Curr. Opin. Struct. Biol. 34, 26-34.
73. Ip, W. K., Takahashi, K., Ezekowitz, R. A., Stuart, L. M. (2009) Mannosebinding lectin and innate immunity. Immunol. Rev. 230, 9-21.
74. De Pascale, G., Cutuli, S. L., Pennisi, M. A., Antonelli, M. (2013) The role of mannose-binding lectin in severe sepsis and septic shock. Mediators Inflamm. 2013, 625803.
75. Yang, W. H., Aziz, P. V., Heithoff, D. M., Mahan, M. J., Smith, J. W., Marth, J. D. (2015) An intrinsic mechanism of secreted protein aging and turnover. Proc. Natl. Acad. Sci. U. S. A. 112, 13657-13662.
76. Drummond, R. A., Brown, G. D. (2013) Signalling C-type lectins in antimicrobial immunity. PLoS Pathog. 9, e1003417.
77. Dambuza, I. M., Brown, G. D. (2015) C-type lectins in immunity: recent developments. Curr. Opin. Immunol. 32, 21-27.
78. Ferwerda, B., Ferwerda, G., Plantinga, T. S., Willment, J. A., van Spriel, A. B., Venselaar, H., Elbers, C. C., Johnson, M. D., Cambi, A., Huysamen, C., Jacobs, L., Jansen, T., Verheijen, K., Masthoff, L., Morré, S. A., Vriend, G., Williams, D. L., Perfect, J. R., Joosten, L. A., Wijmenga, C., van der Meer, J. W., Adema, G. J., Kullberg, B. J., Brown, G. D., Netea, M. G. (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361, 1760-1767.
79. Barreto-Bergter, E., Figueiredo, R. T. (2014) Fungal glycans and the innate immune recognition. Front. Cell. Infect. Microbiol. 4, 145.
80. Yonekawa, A., Saijo, S., Hoshino, Y., Miyake, Y., Ishikawa, E., Suzukawa, M., Inoue, H., Tanaka, M., Yoneyama, M., Oh-Hora, M., Akashi, K., Yamasaki, S. (2014) Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan of mycobacteria. Immunity 41, 402-413.
81. Saijo, S., Ikeda, S., Yamabe, K., Kakuta, S., Ishigame, H., Akitsu, A., Fujikado, N., Kusaka, T., Kubo, S., Chung, S. H., Komatsu, R., Miura, N., Adachi, Y., Ohno, N., Shibuya, K., Yamamoto, N., Kawakami, K., Yamasaki, S., Saito, T., Akira, S., Iwakura, Y. (2010) Dectin-2 recognition of a-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32, 681-691.
82. Norimoto, A., Hirose, K., Iwata, A., Tamachi, T., Yokota, M., Takahashi, K., Saijo, S., Iwakura, Y., Nakajima, H. (2014) Dectin-2 promotes house dust mite-induced T helper type 2 and type 17 cell differentiation and allergic airway inflammation in mice. Am. J. Respir. Cell Mol. Biol. 51, 201-209.
83. Rabinovich, G. A., Toscano, M. A. (2009) Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 9, 338-352.
84. Rabinovich, G. A., Toscano, M. A., Ilarregui, J. M., Baum, L. G. 2009. Galectins as novel regulators of immune cell homeostasis and inflammation. In Animal Lectins: a functional view. (G. R. Vasta, H. Ahmed, eds.) Taylor & Francis Group, LLC, Boca Raton, FL, 397-416.
85. Blidner, A. G., Méndez-Huergo, S. P., Cagnoni, A. J., Rabinovich, G. A. (2015) Re-wiring regulatory cell networks in immunity by galectin-glycan interactions. FEBS Lett. 589, 3407-3418.
86. Norling, L. V., Perretti, M., Cooper, D. (2009) Endogenous galectins and the control of the host inflammatory response. J. Endocrinol. 201, 169-184.
87. Nabi, I. R., Shankar, J., Dennis, J. W. (2015) The galectin lattice at a glance. J. Cell Sci. 128, 2213-2219.
88. Liu, F. T., Yang, R. Y., Hsu, D. K. (2012) Galectins in acute and chronic inflammation. Ann. N. Y. Acad. Sci. 1253, 80-91.
89. Wiersma, V. R., de Bruyn, M., Helfrich, W., Bremer, E. (2013) Therapeutic potential of galectin-9 in human disease. Med. Res. Rev. 33 (Suppl 1), E102-E126.
90. Wu, C., Thalhamer, T., Franca, R. F., Xiao, S., Wang, C., Hotta, C., Zhu, C., Hirashima, M., Anderson, A. C., Kuchroo, V. K. (2014) Galectin-9- CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity 41, 270-282.
91. Miwa, H. E., Song, Y., Alvarez, R., Cummings, R. D., Stanley, P. (2012) The bisecting GlcNAc in cell growth control and tumor progression. Glycoconj. J. 29, 609-618.
92. Monslow, J., Govindaraju, P., Puré, E. (2015) Hyaluronan—a functional and structural sweet spot in the tissue microenvironment. Front. Immunol. 6, 231.
93. Ghosh, S., Hoselton, S. A., Dorsam, G. P., Schuh, J. M. (2015) Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease. Immunobiology 220, 575-588.
94. Liang, J., Jiang, D., Noble, P. W. (2016) Hyaluronan as a therapeutic target in human diseases. Adv. Drug Deliv. Rev. 97, 186-203.
95. Varki, A., Etzler, M. E., Cummings, R. D., Esko, J. D. 2009. Discovery and classification of glycan-binding proteins. In Essentials of Glycobiology. (A. Varki, R. D. Cummings, J. D. Esko, H. H. Freeze, P. Stanley, C. R. Bertozzi, G. W. Hart, M. E. Etzler, eds.) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 375-386.
96. Attrill, H., Imamura, A., Sharma, R. S., Kiso, M., Crocker, P. R., van Aalten, D. M. (2006) Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b. J. Biol. Chem. 281, 32774-32783.